Poly [ADP-ribose] polymerase 4 Inhibitors (IC50, Ki)
Structure ▲ ▼ | Compound Name ▲ ▼ | Standard Type ▲ ▼ | Standard Values (in nM) ▲ ▼ |
3,5,7,8-Tetrahydro-2-[4-(trifluoromethyl)phenyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one | IC50 | 4365.16 [1], 5011.87 [2] | |
Niraparib | IC50 | 330.0 [1], 446.68 [2] | |
Olaparib | IC50 | 407.38 [1] | |
N~2~,N~2~-Dimethyl-N~1~-(6-oxo-5,6-dihydrophenanthridin-2-YL)glycinamide | IC50 | 758.58 [1] | |
Veliparib | IC50 | 3467.37 [1] | |
Rucaparib | IC50 | 831.76 [1] | |
Bmn-673 8R,9S | IC50 | 257.04 [1] | |
4-Methoxybenzamide | IC50 | 65000.0 [1] | |
4,4'-Oxydibenzamide | IC50 | 23000.0 [1] | |
4-Quinazolinol, 5,6,7,8-tetrahydro-2-(4-methyl-1-piperazinyl)- | IC50 | 17000.0 [1] |
References
This online tool may be cited as follows
MLA | "Quest Database™ Poly [ADP-ribose] polymerase 4 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Nov. 2024, https://www.aatbio.com/data-sets/poly-adp-ribose-polymerase-4-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2024, November 21). Quest Database™ Poly [ADP-ribose] polymerase 4 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/poly-adp-ribose-polymerase-4-inhibitors-ic50-ki. | |
BibTeX | EndNote | RefMan |